Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
12
SKYE Quote, Financials, Valuation and Earnings
Last price:
$2.70
Seasonality move
:
59.61%
Day range:
$2.66 - $3.09
52-week range:
$2.25 - $19.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
276.12x
P/B ratio:
1.09x
Volume:
484.7K
Avg. volume:
187.4K
1-year change:
-10.82%
Market cap:
$82.5M
Revenue:
--
EPS (TTM):
-$0.84
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.2M | $1.9M | $2.9M | $6M | $5.8M | |
| Selling, General & Admin | $4.4M | $4.3M | $4.9M | $6.1M | $7.9M | |
| Other Inc / (Exp) | $8.7M | $436.3K | $96.8K | -$6.6M | -$23.2M | |
| Operating Expenses | $6.6M | $6.3M | $7.8M | $12.1M | $13.7M | |
| Operating Income | -$6.6M | -$6.3M | -$7.8M | -$12.1M | -$13.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6K | $1.6K | $2.1K | $6.7K | $3.6K | |
| Net Income to Company | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | |
| Basic EPS (Cont. Ops) | $2.50 | -$7.50 | -$5.00 | -$8.77 | -$5.37 | |
| Diluted EPS (Cont. Ops) | -$12.50 | -$7.50 | -$5.00 | -$8.77 | -$5.37 | |
| Weighted Average Basic Share | $540.6K | $923K | $1.6M | $2.2M | $7M | |
| Weighted Average Diluted Share | $678.2K | $925.7K | $1.6M | $2.2M | $7M | |
| EBITDA | $2.1M | -$5.9M | -$7.7M | -$18.7M | -$36.6M | |
| EBIT | $2.1M | -$5.9M | -$7.8M | -$18.8M | -$36.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$6.6M | -$6.3M | -$7.8M | -$12.1M | -$13.7M | |
| Operating Income (Adjusted) | $2.1M | -$5.9M | -$7.8M | -$18.8M | -$36.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $346.2K | $327.7K | $1.8M | $1.3M | $4.9M | |
| Selling, General & Admin | $1.2M | $1.5M | $1.1M | $2.2M | $4.6M | |
| Other Inc / (Exp) | $424.1K | $189.7K | $6.2K | -$21.2M | $4.6M | |
| Operating Expenses | $1.5M | $1.8M | $2.9M | $3.5M | $9.5M | |
| Operating Income | -$1.5M | -$1.8M | -$2.9M | -$3.5M | -$9.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$1.3M | -$1.8M | -$3.1M | -$24.9M | -$3.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$1.3M | -$1.8M | -$3.1M | -$24.9M | -$3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.3M | -$1.8M | -$3.1M | -$24.9M | -$3.9M | |
| Basic EPS (Cont. Ops) | -$2.50 | -$1.10 | -$1.58 | -$3.17 | -$0.10 | |
| Diluted EPS (Cont. Ops) | -$2.50 | -$1.10 | -$1.58 | -$3.17 | -$0.10 | |
| Weighted Average Basic Share | $1M | $1.7M | $2M | $7.9M | $38.8M | |
| Weighted Average Diluted Share | $1M | $1.7M | $2M | $7.9M | $38.8M | |
| EBITDA | -$1.1M | -$1.6M | -$2.9M | -$24.6M | -$3.5M | |
| EBIT | -$1.1M | -$1.6M | -$2.9M | -$24.7M | -$3.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$1.5M | -$1.8M | -$2.9M | -$3.5M | -$9.5M | |
| Operating Income (Adjusted) | -$1.1M | -$1.6M | -$2.9M | -$24.7M | -$3.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.3M | $2.2M | $5.6M | $5.8M | $12.5M | |
| Selling, General & Admin | $4.5M | $4.5M | $5.9M | $6.9M | $15.7M | |
| Other Inc / (Exp) | $7.4M | -$48.8K | $207.6K | -$29.9M | $5.8M | |
| Operating Expenses | $6.8M | $6.7M | $11.5M | $12.7M | $28.2M | |
| Operating Income | -$6.8M | -$6.7M | -$11.5M | -$12.7M | -$28.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$204.9K | -$7.5M | -$12.1M | -$43.1M | -$21.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $5.2K | $10.1K | |
| Net Income to Company | -$206.5K | -$7.5M | -$12.1M | -$43.1M | -$21.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$206.5K | -$7.5M | -$12.1M | -$43.1M | -$21.2M | |
| Basic EPS (Cont. Ops) | $2.50 | -$8.60 | -$6.58 | -$9.28 | -$0.84 | |
| Diluted EPS (Cont. Ops) | -$12.50 | -$8.60 | -$6.58 | -$9.28 | -$0.84 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $614.7K | -$6.7M | -$11.2M | -$42.4M | -$19.5M | |
| EBIT | $613.3K | -$6.8M | -$11.3M | -$42.6M | -$19.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$6.8M | -$6.7M | -$11.5M | -$12.7M | -$28.2M | |
| Operating Income (Adjusted) | $613.3K | -$6.8M | -$11.3M | -$42.6M | -$19.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.6M | $1.8M | $4.5M | $4.2M | $10.9M | |
| Selling, General & Admin | $3.4M | $3.6M | $4.6M | $5.4M | $13.2M | |
| Other Inc / (Exp) | $433.7K | -$51.4K | $59.4K | -$23.2M | $5.8M | |
| Operating Expenses | $5M | $5.4M | $9M | $9.6M | $24.1M | |
| Operating Income | -$5M | -$5.4M | -$9M | -$9.6M | -$24.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5.1M | -$6M | -$9.6M | -$33.2M | -$16.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6K | $1.6K | $5.1K | $3.6K | $10.1K | |
| Net Income to Company | -$5.1M | -$6M | -$9.6M | -$33.2M | -$16.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.1M | -$6M | -$9.6M | -$33.2M | -$16.8M | |
| Basic EPS (Cont. Ops) | -$7.50 | -$6.10 | -$6.58 | -$5.34 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -$7.50 | -$6.10 | -$6.58 | -$5.34 | -$0.48 | |
| Weighted Average Basic Share | $2.5M | $4.5M | $6M | $15.5M | $105.5M | |
| Weighted Average Diluted Share | $2.5M | $4.5M | $6M | $15.5M | $105.5M | |
| EBITDA | -$4.5M | -$5.4M | -$8.9M | -$32.6M | -$15.5M | |
| EBIT | -$4.5M | -$5.4M | -$9M | -$32.7M | -$15.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$5M | -$5.4M | -$9M | -$9.6M | -$24.1M | |
| Operating Income (Adjusted) | -$4.5M | -$5.4M | -$9M | -$32.7M | -$15.6M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8M | $2.5M | $9M | $1.2M | $1.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $152.7K | $190.1K | $567.7K | $882.2K | $597.7K | |
| Other Current Assets | $7.6K | $280 | $56.9K | $306.1K | $558.3K | |
| Total Current Assets | $2M | $2.7M | $9.6M | $8.9M | $11.7M | |
| Property Plant And Equipment | $2K | $7.3K | $234.7K | $159.1K | $281.3K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $8.3K | $8.3K | $8.3K | |
| Total Assets | $2M | $2.7M | $9.9M | $9.1M | $11.9M | |
| Accounts Payable | $139.8K | $381.4K | $900K | $1.8M | $1.2M | |
| Accrued Expenses | $420.4K | $303.2K | $519.4K | $763K | $1.3M | |
| Current Portion Of Long-Term Debt | -- | $64.1K | $2M | $1.9M | $4.4M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $82.4K | $78.7K | $72K | |
| Other Current Liabilities | $410.6K | $38.6K | $435.6K | $7.5M | $7M | |
| Total Current Liabilities | $970.8K | $787.2K | $3.9M | $12.1M | $13.9M | |
| Long-Term Debt | $387.1K | $1.4M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4M | $2.2M | $4M | $12.1M | $14.1M | |
| Common Stock | $182.9K | $288.1K | $476.1K | $3.7K | $12.4K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $548.1K | $450.8K | $5.9M | -$3M | -$2.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $548.1K | $450.8K | $5.9M | -$3M | -$2.1M | |
| Total Liabilities and Equity | $2M | $2.7M | $9.9M | $9.1M | $11.9M | |
| Cash and Short Terms | $1.8M | $2.5M | $9M | $1.2M | $1.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.2M | $11.1M | $415.4K | $5.1M | $67.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $116.2K | $339.6K | $708.5K | $207.2K | $2.9M | |
| Other Current Assets | $3.3K | -- | $166.4K | $17.3K | $430.7K | |
| Total Current Assets | $4.3M | $11.4M | $2.7M | $15.3M | $79.8M | |
| Property Plant And Equipment | $890 | $245K | $177.2K | $309.8K | $1.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $8.3K | $8.3K | $8.3K | $26.3K | |
| Total Assets | $4.3M | $11.7M | $2.9M | $15.6M | $81.5M | |
| Accounts Payable | $753K | $339K | $2.2M | $1.6M | $780K | |
| Accrued Expenses | $81.8K | $393.7K | $749.7K | $1.3M | $968K | |
| Current Portion Of Long-Term Debt | $71.1K | -- | $2.5M | $4.2M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $63.6K | $92.4K | $68.7K | $82.9K | |
| Other Current Liabilities | $305K | $705.3K | $629.5K | $6.5M | $3.8M | |
| Total Current Liabilities | $1.2M | $1.5M | $6.1M | $13.7M | $5.6M | |
| Long-Term Debt | $1.3M | $1.8M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5M | $3.4M | $6.2M | $13.9M | $5.7M | |
| Common Stock | $250.1K | $476.1K | $495.9K | $12.3K | $30.3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.9M | $8.3M | -$3.3M | $1.7M | $75.8M | |
| Total Liabilities and Equity | $4.3M | $11.7M | $2.9M | $15.6M | $81.5M | |
| Cash and Short Terms | $4.2M | $11.1M | $415.4K | $5.1M | $67.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | |
| Depreciation & Amoritzation | $1.5K | $1.9K | $34.1K | $115K | $124.3K | |
| Stock-Based Compensation | $680.5K | $302.7K | $869.2K | $629K | $987.5K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6M | -$6.1M | -$6.5M | -$12.7M | -$14M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$7.2K | -$90.9K | $5.2M | $6.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4M | $566.7K | -- | $680.9K | $5M | |
| Long-Term Debt Repaid | -$4M | -- | -- | -$891.7K | -$265.4K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6M | $6.7M | $13.1M | -$208.8K | $16.4M | |
| Beginning Cash (CF) | $1.9M | $1.8M | $2.5M | $9M | $1.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$23.4K | $639.5K | $6.5M | -$7.7M | $9.1M | |
| Ending Cash (CF) | $1.8M | $2.5M | $9M | $1.2M | $10.3M | |
| Levered Free Cash Flow | -$6M | -$6.1M | -$6.6M | -$12.8M | -$14M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.3M | -$1.8M | -$3.1M | -$24.9M | -$3.9M | |
| Depreciation & Amoritzation | $370 | $7.5K | $28.8K | $28.8K | $66K | |
| Stock-Based Compensation | $148.4K | $489K | $144.1K | $160.2K | $1.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2M | -$1.5M | -$2.1M | -$4.1M | -$5.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -$355.7K | -- | -- | |
| Cash From Investing | -- | -$26.7K | -$366.1K | $1.1M | -$1.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5M | -- | |
| Long-Term Debt Repaid | -- | -- | -$91.9K | -$74K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6.1M | $7.4M | -$91.9K | $16.6M | -- | |
| Beginning Cash (CF) | $107.1K | $5.2M | $2.9M | $558K | $83.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.1M | $5.9M | -$2.5M | $13.7M | -$6.7M | |
| Ending Cash (CF) | $4.2M | $11.1M | $420K | $14.2M | $76.5M | |
| Levered Free Cash Flow | -$2M | -$1.5M | -$2.1M | -$4.1M | -$6.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$206.5K | -$7.5M | -$12.1M | -$43.1M | -$21.2M | |
| Depreciation & Amoritzation | $1.5K | $10.2K | $108.2K | $127.4K | $151.7K | |
| Stock-Based Compensation | $407K | $808.8K | $547.8K | $597.8K | $6.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | -$6.3M | -$9.8M | -$15M | -$20.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -$436.6K | $436.6K | -- | |
| Cash From Investing | -- | -$44.1K | -$506.1K | $12.3M | -$343K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$244.9K | -$889.4K | -$22.7K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $8.7M | $13.2M | -$326.7K | $16.5M | $83.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.9M | $6.9M | -$10.7M | $13.8M | $62.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5.8M | -$6.3M | -$9.9M | -$15M | -$22.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.1M | -$6M | -$9.6M | -$33.2M | -$16.8M | |
| Depreciation & Amoritzation | $1.1K | $9.4K | $83.5K | $95.9K | $123.4K | |
| Stock-Based Compensation | $241.2K | $747.3K | $425.8K | $394.7K | $6.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.3M | -$4.5M | -$7.9M | -$10.1M | -$17.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -$436.6K | -- | -- | |
| Cash From Investing | -- | -$36.8K | -$452.1K | $6.6M | -$336K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $566.7K | -- | -- | $5M | -- | |
| Long-Term Debt Repaid | -- | -- | -$244.9K | -$242.7K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6.7M | $13.2M | -$243K | $16.5M | $83.6M | |
| Beginning Cash (CF) | $2.5M | $12.8M | $17.9M | $4.5M | $186M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4M | $8.6M | -$8.6M | $13M | $66.2M | |
| Ending Cash (CF) | $4.9M | $21.4M | $9.4M | $17.4M | $252.1M | |
| Levered Free Cash Flow | -$4.3M | -$4.5M | -$7.9M | -$10.1M | -$18.6M | |
Get SKYE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SKYE
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
1.09x
1.85x
Price / LTM sales
276.12x
1.86x
Growth Metrics
SKYE
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.25
-$0.20
Profitability
SKYE
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
May
8
Estimated Next Earnings Date
Feb
6
Balance Sheet
SKYE
Sector
Total cash
$67.4M
$47M
Short term investments
--
$45.2M
Total assets
$11.9M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
